Page last updated: 2024-11-05

thalidomide and Schistosomiasis mansoni

thalidomide has been researched along with Schistosomiasis mansoni in 1 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lima, CB1
Iglesias, KB1
Andrade, ZA1

Other Studies

1 other study available for thalidomide and Schistosomiasis mansoni

ArticleYear
Thalidomide failed to inhibit angiogenesis and fibrosis in hepatic schistosomiasis of the mouse.
    Memorias do Instituto Oswaldo Cruz, 2007, Volume: 102, Issue:7

    Topics: Angiogenesis Inhibitors; Animals; Disease Models, Animal; Female; Liver; Liver Cirrhosis; Male; Mice

2007